News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
140 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32529)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (8)
2 (146)
3 (83)
4 (7)
5 (215)
6 (50)
7 (4)
8 (8)
9 (162)
10 (176)
11 (140)
12 (138)
13 (79)
14 (3)
15 (2)
16 (148)
17 (198)
18 (151)
19 (189)
20 (83)
21 (5)
22 (6)
23 (133)
24 (183)
25 (184)
26 (185)
27 (83)
28 (1)
29 (3)
30 (152)
31 (162)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
CORRECTING and REPLACING Seattle Genetics Announces Publication of Results from Two Tucatinib Phase 1b Clinical Trials in HER2-Positive Metastatic Breast Cancer
Results of Combination “Triplet” of Tucatinib with Trastuzumab and Capecitabine Published in The Lancet Oncology
July 11, 2018
·
10 min read
Join Cannabics Pharmaceuticals at the National Cannabis Industry Association’s Cannabis Business Summit and Expo Held at San Jose Convention Center, California USA, July 25-27, 2018
Cannabics Pharmaceuticals Inc. announced that senior members of its team will be attending the National Cannabis Industry Association Business Conference and Expo, to be held in San Jose convention center, California, USA, on July 25th-27th 2018, and will be available for one on one meetings.
July 11, 2018
·
3 min read
Deals
CVS Health Corporation Announces Quarterly Dividend
CVS Health Corporation announced that its board of directors has approved a quarterly dividend of $0.50 (50 cents) per share on the corporation’s common stock.
July 11, 2018
·
1 min read
Deals
Biorem Announces Stock Option Grant
BIOREM Inc. announces that, pursuant to its incentive Stock Option Plan
July 11, 2018
·
1 min read
Autism - A Pipeline Analysis Report 2018 | Technavio
Technavio has announced its pipeline analysis report on the autism market.
July 11, 2018
·
3 min read
Global Robotic Medical Imaging Systems Market 2018-2022| Technological Innovations to Drive Growth| Technavio
The global robotic medical imaging systems market 2018-2022 is expected to register a CAGR of around 15% during the forecast period, according to the latest market research report by Technavio.
July 11, 2018
·
4 min read
Policy
Lexion Medical Receives $12.3 Million on July 10, 2018, of which $10 Million was a PUNITIVE DAMAGE AWARD, from SurgiQuest, a Subsidiary of CONMED, the Manufacturer of the AIRSEAL® Insufflator, for False Advertising.
In an Unusual Move, Conmed DID NOT Appeal the Jury and Federal Court’s Findings.
July 11, 2018
·
5 min read
Policy
West Virginia Escalates War on Pain Control, States the Association of American Physicians and Surgeons (AAPS)
West Virginia has enacted another impediment for physicians who use these drugs for their necessary, appropriate purpose of controlling severe pain, states the Association of American Physicians and Surgeons (AAPS).
July 11, 2018
·
1 min read
BioForest
Nohla Therapeutics Announces Second Closing of $56 Million Series B FinancingAdditional $11 Million Raised from Three New International Investors and One Existing Investor
Nohla Therapeutics announced the second closing of its Series B financing, bringing the total amount raised in this round to $56 million.
July 11, 2018
·
2 min read
Business
Charles River Laboratories Schedules Second-Quarter 2018 Earnings Release and Conference Call
– Schedules Investor Day on August 14th –
July 11, 2018
·
1 min read
Previous
11 of 14
Next